1449-1463
ORIGINAL COMMUNICATION
Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
Multiple Sclerosis Therapy Consensus Group (MSTCG), H. Wiendl, K. V. Toyka, P. Rieckmann and R. Gold, et al.
1464-1472
ORIGINAL COMMUNICATION
Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles
Katharina Stoeck, Klaus Hess, Lorenz Amsler, Tobias Eckert and Dieter Zimmermann, et al.
1473-1478
ORIGINAL COMMUNICATION
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS
D. L. Arnold, D. Campagnolo, H. Panitch, A. Bar-Or and J. Dunn, et al.
1479-1482
ORIGINAL COMMUNICATION
Vestibular neuritis: Vertigo and the high-acceleration vestibulo-ocular reflex
A. Palla, D. Straumann and A. M. Bronstein
1483-1485
ORIGINAL COMMUNICATION
Frequency of nocturnal sudden death in patients with multiple system atrophy
T. Shimohata, T. Ozawa, H. Nakayama, M. Tomita and H. Shinoda, et al.
1486-1494
Original Communication
Development of classification models for early identification of persons at risk for persistent cognitive decline
T. N. van den Kommer, H. C. Comijs, M. G. Dik, C. Jonker and D. J. H. Deeg
1495-1502
Original Communication
Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma – Feasibility and outcome of a combined local treatment concept
O. Schnell, K. Schöller, M. Ruge, A. Siefert and J.-C. Tonn, et al.
1503-1507
ORIGINAL COMMUNICATION
Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke
M. Arnold, M. Halpern, N. Meier, U. Fischer and T. Haefeli, et al.
1508-1514
Original Communication
Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
S. Presslauer, D. Milosavljevic, T. Brücke, P. Bayer and W. Hübl
1515-1520
ORIGINAL COMMUNICATION
Neuropsychiatric symptoms three years after subthalamic DBS in PD patients
A case-control study
Lorys Castelli, Maurizio Zibetti, Laura Rizzi, Marcella Caglio and Michele Lanotte, et al.
1521-1525
ORIGINAL COMMUNICATION
The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis
V. Le Cam-Duchez, A. Bagan-Triquenot, V. Barbay, B. Mihout and J. Y. Borg
1526-1533
ORIGINAL COMMUNICATION
Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci
H. Koike, Y. Kawagashira, M. Iijima, M. Yamamoto and N. Hattori, et al.
1534-1540
ORIGINAL COMMUNICATION
Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington’s disease
M. E. Busse, G. Hughes, C. M. Wiles and A. E. Rosser
1541-1544
ORIGINAL COMMUNICATION
Downbeat positioning nystagmus is a common clinical feature despite variable phenotypes in an FHM1 family
Ichiro Yabe, Mayumi Kitagawa, Yashio Suzuki, Keishi Fujiwara and Takahito Wada, et al.
1545-1548
ORIGINAL COMMUNICATION
Accuracy and inter-observer variation in the classification of dysarthria from speech recordings
S. Fonville, H. B. van der Worp, P. Maat, M. Aldenhoven and A. Algra, et al.
1549-1554
ORIGINAL COMMUNICATION
Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy
Giuseppe Plazzi, Francesca Poli, Christian Franceschini, Antonia Parmeggiani and Piero Pirazzoli, et al.
1555-1560
ORIGINAL COMMUNICATION
Optical coherence tomography in multiple sclerosis
Thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy
M. Siger, K. Dzięgielewski, L. Jasek, M. Bieniek and A. Nicpan, et al.
1561-1566
ORIGINAL COMMUNICATION
Status Epilepticus Severity Score (STESS)
A tool to orient early treatment strategy
Andrea O. Rossetti, Giancarlo Logroscino, Tracey A. Milligan, Costas Michaelides and Christiane Ruffieux, et al.
1567-1573
ORIGINAL COMMUNICATION
Electrical somatosensory stimulation modulates hand motor function in healthy humans
Iris B. M. Koesler, Manuel Dafotakis, Mitra Ameli, Gereon R. Fink and Dennis A. Nowak
1574-1579
ORIGINAL COMMUNICATION
Neuroleptic-induced parkinsonism is associated with olfactory dysfunction
Stephanie Krüger, Antje Haehner, Claudia Thiem and Thomas Hummel
1580-1587
ORIGINAL COMMUNICATION
A comprehensive model of health-related quality of life in Parkinson’s disease
M. Visser, S. M. van Rooden, D. Verbaan, J. Marinus and A. M. Stiggelbout, et al.
1588-1589
LETTER TO THE EDITORS
Meningitis, cranial nerve palsies and bilateral cerebral infarcts
A neurological variant of Lemierre’s syndrome
E. J. van Dijk, J. C. van Swieten and P. J. Koudstaal
1590-1592
LETTER TO THE EDITORS
Intravascular lymphomatosis of the nervous system
M. Szots, A. Szomor, F. Kover, L. Pajor and S. Komoly, et al.
1593-1595
LETTER TO THE EDITORS
MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS
S. Stoquart-ElSankari, P. Lehmann, B. Périn, C. Gondry-Jouet and O. Godefroy
1596
LETTER TO THE EDITORS
Heart valve abnormalities
in Parkinson’s disease treated with dopamine agonists
M. Bareš, I. Rektorová, L. Krajčovičová and I. Rektor
1597
LETTER TO THE EDITORS
Reply: Heart valve abnormalities in Parkinson’s disease treated with dopamine agonists
E. Růžička, H. Línková, M. Pěnička, O. Ulmanová and L. Nováková, et al.
1598-1599
LETTER TO THE EDITORS
New liquid intravenous
immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy
A prospective study of efficacy, safety and tolerability
E. A. Cats, W.-L. van der Pol, S. Piepers, N. C. Notermans and R. M. van den Berg-Vos, et al.
1600-1602
LETTER TO THE EDITORS
Benign paroxysmal tonic
upgaze, benign paroxysmal torticollis, episodic ataxia and
CACNA1A
mutation in a family
A. Roubertie, B. Echenne, J. Leydet, S. Soete and B. Krams, et al.
1603-1604
LETTER TO THE EDITORS
New-onset focal epilepsy
with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin
M. Marnane, A. Vincent and M. Hutchinson
1605-1606
LETTER TO THE EDITORS
Pseudomonous putida
meningitis in a healthy adult
Shuta Toru, Tetsuro Maruyama, Takumi Hori, Naoki Gocho and Takayoshi Kobayashi
1607-1608
Pioneers in Neurology
Hans Steinert (1875–1911)
A. Wagner and H. Steinberg
1609-1612
JOURNAL CLUB
Stroke I: Use an antiplatelet agent and treat hypertension – two negative studies and more
Michael Strupp
1613-1615
COMMUNICATIONS
Communications of the European Neurological Society